Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis

Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis

Objectives To compare the impact of Psoriasis Area and Severity Index (PASI) response on total work productivity impairment (TWPI) in patients with moderate-to-severe psoriasis; to compare TWPI and associated indirect costs among patients treated with risankizumab, adalimumab, ustekinumab, and place...

Full description

Bibliographic Details
Main Authors: Mark Lebwohl, Ahmed M. Soliman, Hongbo Yang, Jessie Wang, Jonathan Freimark, Lluís Puig
Format: Article
Language:English
Published: Taylor & Francis Group 2022-05-01
Series:Journal of Dermatological Treatment
Subjects:
indirect costs
moderate-to-severe psoriasis
pasi
risankizumab
Online Access:http://dx.doi.org/10.1080/09546634.2021.1919287

Internet

http://dx.doi.org/10.1080/09546634.2021.1919287

Similar Items